Review



blebbistatin bleb  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    MedChemExpress blebbistatin bleb
    Blebbistatin Bleb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 40 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blebbistatin+bleb/pmc13081057-167-0-3?v=MedChemExpress
    Average 95 stars, based on 40 article reviews
    blebbistatin bleb - by Bioz Stars, 2026-08
    95/100 stars

    Images



    Similar Products

    95
    MedChemExpress blebbistatin bleb
    Blebbistatin Bleb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blebbistatin+bleb/pmc13081057-167-0-3?v=MedChemExpress
    Average 95 stars, based on 1 article reviews
    blebbistatin bleb - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    90
    Beyotime non-muscle myosin iia inhibitor blebbistatin bleb
    Non Muscle Myosin Iia Inhibitor Blebbistatin Bleb, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blebbistatin+bleb/pm39733514-64-1-7?v=Beyotime
    Average 90 stars, based on 1 article reviews
    non-muscle myosin iia inhibitor blebbistatin bleb - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    95
    Selleck Chemicals blebbistatin bleb

    Blebbistatin Bleb, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blebbistatin+bleb/pmc11530898-5-0-3?v=Selleck+Chemicals
    Average 95 stars, based on 1 article reviews
    blebbistatin bleb - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    95
    MedChemExpress bleb

    Bleb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blebbistatin+bleb/pm38639486-212-6-11?v=MedChemExpress
    Average 95 stars, based on 1 article reviews
    bleb - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    90
    Cayman Chemical blebbistatin bleb
    ( A–C ) B-cells from mice expressing the GFP fusion of non-muscle myosin IIA (GFP-NMIIA) transgene were treated with DMSO or Wisko (10 µM) 10 min before and during incubation with Fab’-PLB. The B-cell contact zones were imaged live using total internal reflection fluorescence microscopy (TIRF). Shown are representative TIRF images of DMSO- and Wisko-treated B-cells at 30 s (during spreading) and 2 min 30 s (after maximal spreading) post landing ( A Scale bars, 2 µm), the averaged GFP-NMIIA MFI (± SEM) ( B ), and the initial rates of increasing (± SEM) of GFP-NMIIA in the contact zone (the slope of the initial GFP-NMIIA MFI versus time curves of individual cells) ( C ). Data points represent individual cells from three independent experiments with ~6 cells per condition per experiment. *p<0.05, ***p<0.001, by Kolmogorov-Smirnov test ( B ) or non-parametric student’s t -test ( C ). ( D ) Primary B-cells from mice expressing both GFP-NMIIA and LifeAct-RFP transgenes were incubated with Fab’-PLB at 37 °C and imaged live by TIRF. Shown are a representative TIRF image of a cell and a kymograph generated from time-lapse TIRF images at the yellow line. The purple arrow indicates the starting point of contraction, the white arrow GFP-NMIIA recruitment proximal to the spreading membrane, and the yellow arrow an F-actin (LifeAct-RFP) focus originating at the lamellipodia and moving away from the spreading membrane. ( E, F ) Primary B-cells from flox control, Wasp germline knockout (WKO), and B-cell-specific N-wasp knockout mice (cNKO) mice were incubated with Fab’-PLB for indicated times. Cells were fixed, permeabilized, stained for non-muscle myosin II (NMII) light chain, and imaged by interference reflection microscopy (IRM) and TIRF. Shown are representative IRM and TIRF images ( E ) and percentages (± SD) of B-cells with the NMII ring-like structure in individual images ( F ), identified by visual inspection. The data were generated from three independent experiments with five images per condition per experiment. Scale bars, 2 µm. *p<0.05, **p<0.01, ***p<0.001, by non-parametric student’s t -test. ( G, H ) Wild-type (WT) splenic B-cells were treated with DMSO or <t>Blebbistatin</t> (Bleb, 50 µM) 20 min before and during incubation with Fab’-PLB at 37 °C. Cells were fixed at 2 and 4 min, permeabilized, stained with phalloidin, and imaged by TIRF. Shown are representative TIRF images of the B-cell contact zone ( G ) and percentages of cells (± SEM) with inner F-actin foci forming ring-like distribution ( H ), determined as described in . Data were generated from three independent experiments with ~50 cells per condition per experiment with different color dots representing individual experiments. Scale bar, 2 µm. *p<0.05, **p<0.01 by paired student’s t -test. MATLAB codes were used for detecting the B-cell contact zone and quantifying NMII FI [ , and ].
    Blebbistatin Bleb, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blebbistatin+bleb/pmc10715734-346-0-4?v=Cayman+Chemical
    Average 90 stars, based on 1 article reviews
    blebbistatin bleb - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Millipore blebbistatin (bleb
    (A) Effect of TAT-C3 transferase, an inhibitor of Rho proteins. Upper panel, F-actin staining of non-infected CESCs treated with 16 µg/mL of TAT-C3 transferase (bar, 20 µm). Lower panel, a picture of a representative BAC20-EGFP infection plaque obtained with 16 µg/mL of TAT-C3 transferase (bar, 200 µm). Right panel, the graph shows a quantitative analysis of plaques size in one of two to three representative experiments (***, p<0.001). The error bars represent the SEM of 50 plaques size. (B) Effect of LPA, an activator of Rho proteins, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (C) Effect of Y-27632, an inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques sizes (right panel), as in A (***, p<0.001). (D) Effect of Fasudil, a second inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (*, 0.1<p<0.5; ***, p<0.001). (E) After a 4-day treatment with the indicated concentrations of Y-27632 (left) or Fasudil (right), MLC phosphorylation was monitored by Western blotting with an anti-phospho-MLC (Thr18/Ser19) antibody followed by an alkaline phosphatase-labeled secondary antibody. An anti-GAPDH antibody was used to control the amount of proteins in each lysate. (F) Effect of <t>blebbistatin,</t> an inhibitor of NMIIA ATPase activity, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (E) One of two representative experiments showing the relative cell viability after a 4-day treatment with the highest concentration of TAT-C3 transferase, LPA, Y-27632, Fasudil and blebbistatin are presented. Values were measured and normalized as above. Error bars represent the SEM.
    Blebbistatin (Bleb, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blebbistatin+bleb/pmc03428312-260-30-33?v=Millipore
    Average 90 stars, based on 1 article reviews
    blebbistatin (bleb - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    PeproTech blebbistatin (bleb)
    (A) Effect of TAT-C3 transferase, an inhibitor of Rho proteins. Upper panel, F-actin staining of non-infected CESCs treated with 16 µg/mL of TAT-C3 transferase (bar, 20 µm). Lower panel, a picture of a representative BAC20-EGFP infection plaque obtained with 16 µg/mL of TAT-C3 transferase (bar, 200 µm). Right panel, the graph shows a quantitative analysis of plaques size in one of two to three representative experiments (***, p<0.001). The error bars represent the SEM of 50 plaques size. (B) Effect of LPA, an activator of Rho proteins, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (C) Effect of Y-27632, an inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques sizes (right panel), as in A (***, p<0.001). (D) Effect of Fasudil, a second inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (*, 0.1<p<0.5; ***, p<0.001). (E) After a 4-day treatment with the indicated concentrations of Y-27632 (left) or Fasudil (right), MLC phosphorylation was monitored by Western blotting with an anti-phospho-MLC (Thr18/Ser19) antibody followed by an alkaline phosphatase-labeled secondary antibody. An anti-GAPDH antibody was used to control the amount of proteins in each lysate. (F) Effect of <t>blebbistatin,</t> an inhibitor of NMIIA ATPase activity, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (E) One of two representative experiments showing the relative cell viability after a 4-day treatment with the highest concentration of TAT-C3 transferase, LPA, Y-27632, Fasudil and blebbistatin are presented. Values were measured and normalized as above. Error bars represent the SEM.
    Blebbistatin (Bleb), supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blebbistatin+bleb/pm35929298-143-14-16?v=PeproTech
    Average 90 stars, based on 1 article reviews
    blebbistatin (bleb) - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Optopharma Ltd blebbistatin bleb
    (A) Effect of TAT-C3 transferase, an inhibitor of Rho proteins. Upper panel, F-actin staining of non-infected CESCs treated with 16 µg/mL of TAT-C3 transferase (bar, 20 µm). Lower panel, a picture of a representative BAC20-EGFP infection plaque obtained with 16 µg/mL of TAT-C3 transferase (bar, 200 µm). Right panel, the graph shows a quantitative analysis of plaques size in one of two to three representative experiments (***, p<0.001). The error bars represent the SEM of 50 plaques size. (B) Effect of LPA, an activator of Rho proteins, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (C) Effect of Y-27632, an inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques sizes (right panel), as in A (***, p<0.001). (D) Effect of Fasudil, a second inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (*, 0.1<p<0.5; ***, p<0.001). (E) After a 4-day treatment with the indicated concentrations of Y-27632 (left) or Fasudil (right), MLC phosphorylation was monitored by Western blotting with an anti-phospho-MLC (Thr18/Ser19) antibody followed by an alkaline phosphatase-labeled secondary antibody. An anti-GAPDH antibody was used to control the amount of proteins in each lysate. (F) Effect of <t>blebbistatin,</t> an inhibitor of NMIIA ATPase activity, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (E) One of two representative experiments showing the relative cell viability after a 4-day treatment with the highest concentration of TAT-C3 transferase, LPA, Y-27632, Fasudil and blebbistatin are presented. Values were measured and normalized as above. Error bars represent the SEM.
    Blebbistatin Bleb, supplied by Optopharma Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blebbistatin+bleb/pm34271288-36-9-44?v=Optopharma+Ltd
    Average 90 stars, based on 1 article reviews
    blebbistatin bleb - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    Image Search Results


    Journal: STAR Protocols

    Article Title: Protocol for the dissociation of adult human primary cardiomyocytes using a methylcellulose-supplemented digestion solution

    doi: 10.1016/j.xpro.2024.103379

    Figure Lengend Snippet:

    Article Snippet: (−)-blebbistatin (Bleb) , Selleck , S7099.

    Techniques: Recombinant, Hood, Microscopy, Blocking Assay, Transferring, Membrane

    ( A–C ) B-cells from mice expressing the GFP fusion of non-muscle myosin IIA (GFP-NMIIA) transgene were treated with DMSO or Wisko (10 µM) 10 min before and during incubation with Fab’-PLB. The B-cell contact zones were imaged live using total internal reflection fluorescence microscopy (TIRF). Shown are representative TIRF images of DMSO- and Wisko-treated B-cells at 30 s (during spreading) and 2 min 30 s (after maximal spreading) post landing ( A Scale bars, 2 µm), the averaged GFP-NMIIA MFI (± SEM) ( B ), and the initial rates of increasing (± SEM) of GFP-NMIIA in the contact zone (the slope of the initial GFP-NMIIA MFI versus time curves of individual cells) ( C ). Data points represent individual cells from three independent experiments with ~6 cells per condition per experiment. *p<0.05, ***p<0.001, by Kolmogorov-Smirnov test ( B ) or non-parametric student’s t -test ( C ). ( D ) Primary B-cells from mice expressing both GFP-NMIIA and LifeAct-RFP transgenes were incubated with Fab’-PLB at 37 °C and imaged live by TIRF. Shown are a representative TIRF image of a cell and a kymograph generated from time-lapse TIRF images at the yellow line. The purple arrow indicates the starting point of contraction, the white arrow GFP-NMIIA recruitment proximal to the spreading membrane, and the yellow arrow an F-actin (LifeAct-RFP) focus originating at the lamellipodia and moving away from the spreading membrane. ( E, F ) Primary B-cells from flox control, Wasp germline knockout (WKO), and B-cell-specific N-wasp knockout mice (cNKO) mice were incubated with Fab’-PLB for indicated times. Cells were fixed, permeabilized, stained for non-muscle myosin II (NMII) light chain, and imaged by interference reflection microscopy (IRM) and TIRF. Shown are representative IRM and TIRF images ( E ) and percentages (± SD) of B-cells with the NMII ring-like structure in individual images ( F ), identified by visual inspection. The data were generated from three independent experiments with five images per condition per experiment. Scale bars, 2 µm. *p<0.05, **p<0.01, ***p<0.001, by non-parametric student’s t -test. ( G, H ) Wild-type (WT) splenic B-cells were treated with DMSO or Blebbistatin (Bleb, 50 µM) 20 min before and during incubation with Fab’-PLB at 37 °C. Cells were fixed at 2 and 4 min, permeabilized, stained with phalloidin, and imaged by TIRF. Shown are representative TIRF images of the B-cell contact zone ( G ) and percentages of cells (± SEM) with inner F-actin foci forming ring-like distribution ( H ), determined as described in . Data were generated from three independent experiments with ~50 cells per condition per experiment with different color dots representing individual experiments. Scale bar, 2 µm. *p<0.05, **p<0.01 by paired student’s t -test. MATLAB codes were used for detecting the B-cell contact zone and quantifying NMII FI [ , and ].

    Journal: eLife

    Article Title: N-WASP-dependent branched actin polymerization attenuates B-cell receptor signaling by increasing the molecular density of receptor clusters

    doi: 10.7554/eLife.87833

    Figure Lengend Snippet: ( A–C ) B-cells from mice expressing the GFP fusion of non-muscle myosin IIA (GFP-NMIIA) transgene were treated with DMSO or Wisko (10 µM) 10 min before and during incubation with Fab’-PLB. The B-cell contact zones were imaged live using total internal reflection fluorescence microscopy (TIRF). Shown are representative TIRF images of DMSO- and Wisko-treated B-cells at 30 s (during spreading) and 2 min 30 s (after maximal spreading) post landing ( A Scale bars, 2 µm), the averaged GFP-NMIIA MFI (± SEM) ( B ), and the initial rates of increasing (± SEM) of GFP-NMIIA in the contact zone (the slope of the initial GFP-NMIIA MFI versus time curves of individual cells) ( C ). Data points represent individual cells from three independent experiments with ~6 cells per condition per experiment. *p<0.05, ***p<0.001, by Kolmogorov-Smirnov test ( B ) or non-parametric student’s t -test ( C ). ( D ) Primary B-cells from mice expressing both GFP-NMIIA and LifeAct-RFP transgenes were incubated with Fab’-PLB at 37 °C and imaged live by TIRF. Shown are a representative TIRF image of a cell and a kymograph generated from time-lapse TIRF images at the yellow line. The purple arrow indicates the starting point of contraction, the white arrow GFP-NMIIA recruitment proximal to the spreading membrane, and the yellow arrow an F-actin (LifeAct-RFP) focus originating at the lamellipodia and moving away from the spreading membrane. ( E, F ) Primary B-cells from flox control, Wasp germline knockout (WKO), and B-cell-specific N-wasp knockout mice (cNKO) mice were incubated with Fab’-PLB for indicated times. Cells were fixed, permeabilized, stained for non-muscle myosin II (NMII) light chain, and imaged by interference reflection microscopy (IRM) and TIRF. Shown are representative IRM and TIRF images ( E ) and percentages (± SD) of B-cells with the NMII ring-like structure in individual images ( F ), identified by visual inspection. The data were generated from three independent experiments with five images per condition per experiment. Scale bars, 2 µm. *p<0.05, **p<0.01, ***p<0.001, by non-parametric student’s t -test. ( G, H ) Wild-type (WT) splenic B-cells were treated with DMSO or Blebbistatin (Bleb, 50 µM) 20 min before and during incubation with Fab’-PLB at 37 °C. Cells were fixed at 2 and 4 min, permeabilized, stained with phalloidin, and imaged by TIRF. Shown are representative TIRF images of the B-cell contact zone ( G ) and percentages of cells (± SEM) with inner F-actin foci forming ring-like distribution ( H ), determined as described in . Data were generated from three independent experiments with ~50 cells per condition per experiment with different color dots representing individual experiments. Scale bar, 2 µm. *p<0.05, **p<0.01 by paired student’s t -test. MATLAB codes were used for detecting the B-cell contact zone and quantifying NMII FI [ , and ].

    Article Snippet: Blebbistatin (Bleb, 50 μM, Cayman Chemicals) was used to inhibit the NMII motor activity ( ).

    Techniques: Expressing, Incubation, Fluorescence, Microscopy, Generated, Membrane, Control, Knock-Out, Staining

    Journal: eLife

    Article Title: N-WASP-dependent branched actin polymerization attenuates B-cell receptor signaling by increasing the molecular density of receptor clusters

    doi: 10.7554/eLife.87833

    Figure Lengend Snippet:

    Article Snippet: Blebbistatin (Bleb, 50 μM, Cayman Chemicals) was used to inhibit the NMII motor activity ( ).

    Techniques: Control, Liposomes, Antibody Labeling, Software

    (A) Effect of TAT-C3 transferase, an inhibitor of Rho proteins. Upper panel, F-actin staining of non-infected CESCs treated with 16 µg/mL of TAT-C3 transferase (bar, 20 µm). Lower panel, a picture of a representative BAC20-EGFP infection plaque obtained with 16 µg/mL of TAT-C3 transferase (bar, 200 µm). Right panel, the graph shows a quantitative analysis of plaques size in one of two to three representative experiments (***, p<0.001). The error bars represent the SEM of 50 plaques size. (B) Effect of LPA, an activator of Rho proteins, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (C) Effect of Y-27632, an inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques sizes (right panel), as in A (***, p<0.001). (D) Effect of Fasudil, a second inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (*, 0.1<p<0.5; ***, p<0.001). (E) After a 4-day treatment with the indicated concentrations of Y-27632 (left) or Fasudil (right), MLC phosphorylation was monitored by Western blotting with an anti-phospho-MLC (Thr18/Ser19) antibody followed by an alkaline phosphatase-labeled secondary antibody. An anti-GAPDH antibody was used to control the amount of proteins in each lysate. (F) Effect of blebbistatin, an inhibitor of NMIIA ATPase activity, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (E) One of two representative experiments showing the relative cell viability after a 4-day treatment with the highest concentration of TAT-C3 transferase, LPA, Y-27632, Fasudil and blebbistatin are presented. Values were measured and normalized as above. Error bars represent the SEM.

    Journal: PLoS ONE

    Article Title: Rho-ROCK and Rac-PAK Signaling Pathways Have Opposing Effects on the Cell-to-Cell Spread of Marek's Disease Virus

    doi: 10.1371/journal.pone.0044072

    Figure Lengend Snippet: (A) Effect of TAT-C3 transferase, an inhibitor of Rho proteins. Upper panel, F-actin staining of non-infected CESCs treated with 16 µg/mL of TAT-C3 transferase (bar, 20 µm). Lower panel, a picture of a representative BAC20-EGFP infection plaque obtained with 16 µg/mL of TAT-C3 transferase (bar, 200 µm). Right panel, the graph shows a quantitative analysis of plaques size in one of two to three representative experiments (***, p<0.001). The error bars represent the SEM of 50 plaques size. (B) Effect of LPA, an activator of Rho proteins, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (C) Effect of Y-27632, an inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques sizes (right panel), as in A (***, p<0.001). (D) Effect of Fasudil, a second inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (*, 0.1

    Article Snippet: Stock solutions were made in dimethyl sulfoxide (DMSO) for: cytochalasin D (CytD) (C8273, Sigma) at 20 mM, jasplakinolide (Jaspl) (J7473, Invitrogen) at 1 mM, IPA-3 (cat#506106, Calbiochem) at 20 mM, blebbistatin (Bleb) (B0560, Sigma) at 25 mM.

    Techniques: Staining, Infection, Western Blot, Labeling, Activity Assay, Concentration Assay